Providing strategic counsel on congressional and administrative issues, including drug pricing, Medicare and Medicaid, 340B, tax and trade, intellectual property, and FDA regulatory matters.
2026 · 1st Quarter (Jan 1 - Mar 31)
ABBVIE, INC.
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Mar 20, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Client
- ABBVIE, INC.
- Filing UUID
- 3fac4d9f-a643-4a93-9160-1855e4394779
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.